Genetic Technologies Limited
🏢 View company profile →13Patents
10Active
13Granted
48Portfolio score
Filing activity: May 30, 2003 → Jul 6, 2021 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8734364B1 | Device and method for obtaining a biological sample | Human Necessities | 12 | Active |
| US9078642B2 | Biological sampling device | Human Necessities | 7 | Active |
| US7785898B2 | Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood | Emerging Cross-Sectional Technologies | 4 | Expired |
| US8827923B2 | Biological sampling device | Human Necessities | 4 | Active |
| US9447467B2 | Methods for obtaining fetal genetic material | Physics | 2 | Active |
| US7615342B2 | ACTN3 genotype screen for athletic performance | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11072830B2 | Methods for breast cancer risk assessment | Chemistry; Metallurgy | 0 | Active |
| US10920279B2 | Method for modifying a treatment regimen of a human female subject | Chemistry; Metallurgy | 0 | Active |
| US10683549B2 | Methods for assessing risk of developing breast cancer | Chemistry; Metallurgy | 0 | Active |
| US11031098B2 | Computer systems and methods for genomic analysis | Emerging Cross-Sectional Technologies | 0 | Active |
| US8315816B2 | Methods of genetic analysis involving the amplification of complementary duplicons | Physics | 0 | Active |
| US8394582B2 | Identification of fetal DNA and fetal cell markers in maternal plasma or serum | Chemistry; Metallurgy | 0 | Expired |
| US11257569B1 | Methods of assessing risk of developing a severe response to coronavirus infection | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.